91 related articles for article (PubMed ID: 1786955)
1. [The preparation of highly purified insulin and its clinical use. Insulin Cooperative Study Group].
Yang J; Fang F; Zhu X; Deng S; Zhou W; Xing Z
Hua Xi Yi Ke Da Xue Xue Bao; 1991 Jun; 22(2):178-80. PubMed ID: 1786955
[TBL] [Abstract][Full Text] [Related]
2. [Determination of insulin, porcine proinsulin and pancreatic polypeptide antibodies in human serum by radioimmunoassay].
Deng SP; Zhou WB; Xiong ZY
Hua Xi Yi Ke Da Xue Xue Bao; 1986 Sep; 17(3):194-8. PubMed ID: 3549531
[No Abstract] [Full Text] [Related]
3. Circulating antibodies in diabetics treated with conventional and purified insulins.
Klaff LJ; Vinik AI; Berelowitz M; Jackson WP
S Afr Med J; 1978 Jul; 54(4):149-53. PubMed ID: 694712
[TBL] [Abstract][Full Text] [Related]
4. Decrease of antibodies to insulin, proinsulin and contaminating hormones after changing treatment from conventional beef to purified pork insulin.
Kurtz AB; Matthews JA; Mustaffa BE; Daggett PR; Nabarro JD
Diabetologia; 1980; 18(2):147-50. PubMed ID: 6988274
[TBL] [Abstract][Full Text] [Related]
5. Antigenicity of "monocomponent" pork insulin in diabetic subjects.
Yue DK; Turtle JR
Diabetes; 1975 Jul; 24(7):625-32. PubMed ID: 1171804
[TBL] [Abstract][Full Text] [Related]
6. [The antigenicity of various new chromatographically purified depot insulin preparations].
Graber D; Fankhauser S
Schweiz Med Wochenschr; 1978 Nov; 108(46):1807-9. PubMed ID: 715418
[TBL] [Abstract][Full Text] [Related]
7. Controlled study comparing treatment with monocomponent insulin and conventional insulin in patients with lipoatrophy.
Czyzyk A; Rogala H; Lawecki J
Acta Diabetol Lat; 1989; 26(1):17-26. PubMed ID: 2665407
[TBL] [Abstract][Full Text] [Related]
8. Antibodies to insulin, pancreatic polypeptide, glucagon, and somatostatin in insulin-treated diabetics.
Fitz-Patrick D; Patel YC
J Clin Endocrinol Metab; 1981 May; 52(5):948-52. PubMed ID: 6112233
[TBL] [Abstract][Full Text] [Related]
9. Antibodies to pancreatic hormones in diabetics treated before 1964 and after 1974.
Meryn S; Spigland I; Bauman WA
Clin Immunol Immunopathol; 1986 Aug; 40(2):291-7. PubMed ID: 2872983
[TBL] [Abstract][Full Text] [Related]
10. Insulin, pancreatic polypeptide, and glucagon antibodies in insulin-dependent diabetes mellitus.
Asplin CM; Hollander P; Pecoraro RE; Brodsky J; Palmer JP
Diabetes Care; 1981; 4(3):337-42. PubMed ID: 7047110
[TBL] [Abstract][Full Text] [Related]
11. The immunogenic properties of highly purified insulin preparations: The clinical importance of insulin-binding antibodies.
Anderson OO
Acta Endocrinol (Copenh); 1975 Apr; 78(4):723-35. PubMed ID: 1173962
[TBL] [Abstract][Full Text] [Related]
12. Autoantibodies to insulin and to proinsulin in type 1 diabetic patients and in at-risk probands differentiate only little between both antigens.
Keilacker H; Rjasanowski I; Besch W; Kohnert KD
Horm Metab Res; 1995 Feb; 27(2):90-4. PubMed ID: 7538970
[TBL] [Abstract][Full Text] [Related]
13. Insulin allergy: reaginic antibodies to insulin and proinsulin.
Kumar D; Rosenquist RJ; Parameswaran V
J Clin Endocrinol Metab; 1979 Aug; 49(2):252-4. PubMed ID: 457844
[TBL] [Abstract][Full Text] [Related]
14. Effects of new insulins on insulin and C-peptide antibodies, insulin dose, and diabetic control.
Peacock I; Tattersall RB; Taylor A; Douglas CA; Reeves WG
Lancet; 1983 Jan; 1(8317):149-52. PubMed ID: 6130198
[TBL] [Abstract][Full Text] [Related]
15. Immunogenicity of highly purified bovine insulin: a comparison with conventional bovine and highly purified human insulins.
Wilson RM; Douglas CA; Tattersall RB; Reeves WG
Diabetologia; 1985 Sep; 28(9):667-70. PubMed ID: 3905477
[TBL] [Abstract][Full Text] [Related]
16. Autoimmunity in diabetics induced by hormonal contaminants of insulin.
Bloom SR; Adrian TE; Barnes AJ; Polak JM
Lancet; 1979 Jan; 1(8106):14-7. PubMed ID: 83463
[TBL] [Abstract][Full Text] [Related]
17. Autoantibodies to recombinant canine proinsulin in canine diabetic patients.
Davison LJ; Herrtage ME; Catchpole B
Res Vet Sci; 2011 Aug; 91(1):58-63. PubMed ID: 20855094
[TBL] [Abstract][Full Text] [Related]
18. Effects of species of origin, purification levels, and formulation on insulin immunogenicity.
Fineberg SE; Galloway JA; Fineberg NS; Goldman J
Diabetes; 1983 Jul; 32(7):592-9. PubMed ID: 6345238
[TBL] [Abstract][Full Text] [Related]
19. Immunogenicity of insulin of various origins.
Reeves WG
Neth J Med; 1985; 28 Suppl 1():43-6. PubMed ID: 3892338
[No Abstract] [Full Text] [Related]
20. [Anti-insulin, proinsulin, pancreatic polypeptide, glucagon and somatostatin antibodies in patients with insulin-dependent diabetes mellitus treated with conventional insulin preparations].
Dominiak K; Gembal M; Horoszek-Maziarz S; Wójcikowski C
Endokrynol Pol; 1987; 38(4):281-90. PubMed ID: 2900755
[No Abstract] [Full Text] [Related]
[Next] [New Search]
